COVID-19 and Its Impact on Cancer Patient’s Outcome and Cancer Research

Abstract

The current coronavirus pandemic has severely impacted the health care system in India and all around the world. All aspects of cancer care, including screening, investigations, treatment, clinical trials and research, have been affected as resources are diverted to combat the pandemic. Cancer patients are more susceptible to infections due to their immunocompromised status, either due to disease or therapy, and subsequently, this may result in in poor outcome, especially in case of coronavirus infection. Multiple studies have shown adverse impact of COVID-19 on cancer patients in form of higher mortality with haematological malignancy being worst affected, and interval between last oncological treatment and infection playing an important role in affecting the prognosis. Impact on clinical trials in oncology has been severe. Enrolment has decreased significantly, many trials have been suspended, and ongoing trials are facing problems with patient evaluations leading to impact on quality of data being generated. Telemedicine is now being used to overcome some of these problems but it has its own limitations and should be used judiciously. The pandemic has given us an opportunity to look into the shortcomings of our cancer care system and to find out ways to overcome them.

Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study

“…During the pandemic, accessing treatment facilities was dramatically affected mainly due to the travel restrictions and also due to the operational restrictions at treatment facilities. (Goyal et al, 2020) The importance of digital infrastructure in health care delivery has been felt significantly (Yadav et al, 2020). Till March 2020, there was no law of providing digital consults to the patients but after the lockdown, the Indian Ministry of Health allowed to provide the full potential of technology in health care delivery (De Guzman and Malik, 2020).…”

Cancer Care Delivery Challenges in India during the COVID-19 Era: Are We Prepared for the Postpandemic Shock?

“…The presence of cancer treatment facilities near patients' residences will greatly support them in the postpandemic era. [ 12 ]…”

Tele-health and cancer care in the era of COVID-19: New opportunities in low and middle income countries (LMICs)

“…As much as clinical trials are suffering from lack of resources and short-staffing, thereby affecting overall subject recruitment; the on-going pandemic may also unfortunately be a deterrent for cancer patients to get enroled into clinical trials as well. Only 20% of institutions are enroling patients for cancer research and approximately 200 trails have been suspended [10] . In March 2020, the Food and Drug Administration (FDA) released a formal statement on guidance regarding conducting clinical trials in light of the COVID-19 pandemic.…”